ALHC241220P17500
- 5.40
- 0.000.00%
Alignment Healthcare Newsroom
J.P. Morgan Maintains Alignment Healthcare(ALHC.US) With Hold Rating, Raises Target Price to $14
J.P. Morgan Sticks to Its Hold Rating for Alignment Healthcare (ALHC)
TD Cowen Maintains Alignment Healthcare(ALHC.US) With Buy Rating, Maintains Target Price $13
Piper Sandler Maintains Alignment Healthcare(ALHC.US) With Buy Rating, Raises Target Price to $14
Alignment Healthcare Analyst Ratings
A Quick Look at Today's Ratings for Alignment Healthcare(ALHC.US), With a Forecast Between $8 to $14
Alignment Healthcare Is Maintained at Neutral by UBS
UBS Maintains Neutral on Alignment Healthcare, Raises Price Target to $12
Barclays Maintains Alignment Healthcare(ALHC.US) With Sell Rating, Raises Target Price to $8
Stifel Maintains Alignment Healthcare(ALHC.US) With Buy Rating, Maintains Target Price $14
William Blair Initiates Alignment Healthcare(ALHC.US) With Buy Rating
Alignment Healthcare Analyst Ratings
Stifel Maintains Alignment Healthcare(ALHC.US) With Buy Rating, Maintains Target Price $14
Stifel Maintains Alignment Healthcare(ALHC.US) With Buy Rating, Raises Target Price to $14
Buy Rating Affirmed for Alignment Healthcare on Strong Growth and Operational Efficiency Prospects Into 2025
Alignment Healthcare Analyst Ratings
Baird Maintains Outperform on Alignment Healthcare, Raises Price Target to $11
Alignment Healthcare Price Target Raised to $10.00/Share From $8.00 by TD Cowen
Piper Sandler Reiterates Overweight on Alignment Healthcare, Raises Price Target to $10
TD Cowen Maintains Alignment Healthcare(ALHC.US) With Buy Rating, Raises Target Price to $10